Related Experiment Videos
[Familial alveolar proteinosis]
Revue De Pneumologie Clinique
|October 31, 2002
Summary
Pulmonary alveolar proteinosis (PAP) is a rare genetic lung disease. Familial PAP may involve surfactant protein B deficiency or issues with the granulocyte colony-stimulating factor receptor, suggesting gene therapy as a future treatment.
Area of Science:
- Pulmonary medicine
- Genetics
- Molecular biology
Background:
- Pulmonary alveolar proteinosis (PAP) is a rare, progressive lung disease with poorly understood pathogenesis.
- Familial forms of PAP suggest a genetic basis, often linked to surfactant protein deficiencies or receptor defects.
Observation:
- Familial PAP is likely inherited via autosomal recessive inheritance.
- Deficiencies in surfactant apoprotein SPB or defective expression of the granulocyte colony-stimulating factor (GM-CSF), IL3, and IL5 receptor are implicated.
Findings:
- Identifies specific genetic defects associated with familial pulmonary alveolar proteinosis.
- Highlights the role of surfactant apoprotein SPB and GM-CSF receptor pathways in disease development.
Implications:
- Suggests gene therapy as a potential future treatment strategy for familial PAP.
- Advances understanding of PAP pathogenesis, paving the way for targeted therapies.